Pharma Marketing Company for Sale in Panchkula, India
Established | 5-10 year(s) |
Employees | 10 - 50 |
Legal Entity | Private Limited Company |
Reported Sales | INR 1 - 2 crore |
Run Rate Sales | INR 1.6 crore |
EBITDA Margin | Nil |
Industries | Pharma Marketing |
Locations | Panchkula |
Local Time | 2:22 PM Asia / Kolkata |
Listed By | Business Owner / Director |
Status | Active |
- We have a good doctor base prescribing our medicines at various headquarters. We are registered in Mumbai.
- We have around 20-25 major doctors prescribing for us at each headquarter.
- Wide stockist network in Punjab, Haryana, Chandigarh, Dehradun, and J&K, Ludhiana, Jalandhar, Amritsar, Khanna, Moga, Hoshiarpur, Bathinda, Mansa, Chandigarh, Panchkula, Panipat, Ambala, Sonipat, Karnal, Hisar, Sirsa, Dehradun, Haridwar, Tohana, Jammu, Srinagar, Anantnag, Sopore.
- We have major salts patented under our name and these are widely available in major hospitals.
- Young, dedicated experienced team.
- Excellent ethical branding of the products comparable with MNCs.
- Team members are given apple iPads as visual aids.
- Payment cycle of monthly payments majority on primary sale with the stockists.
- We have 13 patents filed under our name. 11 are totally cleared and 2 are under opposition.
- Associated with more than 500 doctors directly for the sales but currently we are operating at breakeven.
- Business has a pending loan of INR 30 lakhs and is managed by 3 major shareholders.
1. Rosuvastatin and its combinations with triple combinations.
2. Telmisartan and its combinations.
3. Vildagliptin series.
4. Teneligliptin series.
5. Glimipride-1 and 2 mg and with triple combinations.
6. Dapaglifazone.
7. Pregabalin sustained release.
8.4G combination.
9. Calcium citrate combination.
10. Nano shot of vit D3.
11. Rabeprazole and domperidone.
12. Escitaopram.
13. Multivaitamin for Corona.
- Excellent repute with the leading doctors at each headquarter. They know the company for the last 4 years.
- Consistent team face visiting the doctors. There is a very less attrition rate.
- Experienced, dynamic, young, and sincere team.
- Excellent quality and packaging of the medicines.
- Good stockist network.
- Payment cycle of monthly payments majority on primary sale with the stockists.
Tangible assets:
1. Ipads.
2. Stocks of around INR 18 lacs at CFA (manufacturing cost) and INR 15-17 lacs at the stockists.
-
Earlier than 15 daysSupply Chain Head, FMCG, Ahmedabad, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysCEO, Delhi, M&A Advisor connected with the Business
-
Earlier than 15 daysScientist, Research Services, Brisbane, Individual Investor / Buyer connected with the Business